Posts tagged first-in-human
Avantec Vascular Chooses bioaccess™ for a First-In-Human Clinical Study in Latin America
Avantec Vascular Chooses bioaccess™ for a First-In-Human Clinical Study in Latin America

Avantec Vascular Corporation (https://www.avantecvascular.com/), a company in the San Francisco Bay Area dedicated to advancing vascular therapies through innovation, has chosen Latin America as the destination for the first-in-human study of an innovative vascular device. bioaccess™ will help Avantec Vascular with the selection of a principal investigator, the submission of its regulatory dossier for the ministry of health approvals, and other activities related to carrying out the study.

Read More
Clinical TrialsJulio G. Martinez-Clarklatin america, Colombia, MEXICO, first-in-human, clinical study, avantec vascularComment
PAVmed Selects Colombia for a First-in-Human Study on its PortIO™ Medical Device
PAVmed Selects Colombia for a First-in-Human Study on its PortIO™ Medical Device

PAVmed Inc. (Nasdaq:PAVM), is a highly-differentiated, multi-product medical device company employing a unique and proven business model designed to advance products from concept to commercialization much more rapidly and with significantly less capital than the typical medical device company. PAVmed has selected bioaccess.™ as its contract research organization (CRO) for a first-in-human clinical trial of its PortIO medical device. The clinical trial will be led by Dr. Jorge Humberto Ulloa —a leading vascular surgeon who trained at the Walter Reed Army Medical Center Washington DC— and will be conducted at Cirulaser Andes (“Cirulaser”) in Bogota, Colombia — a specialized vascular center affiliated with Hospital Universitario de la Fundación Santa Fé de Bogotá ("FSFB").

Read More
Clinical TrialsJulio G. Martinez-ClarkPAVmed, PortIO, Cirulaser Andes, Jorge Humberto Ulloa, first-in-human, first-in-human clinical trial in Colombia, first-in-human colombiaComment
CoapTech Considers Colombia For its First-In-Man Clinical Trial to Prove The Efficacy of its Enteral Nutrition Feeding Tube Placement Technology
CoapTech Considers Colombia For its First-In-Man Clinical Trial to Prove The Efficacy of its Enteral Nutrition Feeding Tube Placement Technology

CoapTech is an early-stage medical device company with a patent-pending, platform technology to disrupt the market for enteral nutrition feeding tubes. The CoapTech system will de-skill the procedure for feeding tube placement, offering a simpler, safer, and more affordable method. CoapTech has chosen Colombia to conduct its first-in-man clinical trial. CoapTech has chosen BIOACCESS™ as its CRO to explore conducting this trial in Colombia by helping it find a qualified site and investigator.

Read More
Clinical TrialsJulio G. Martinez-ClarkCoapTech, Percutaneous Ultrasound Gastrostomy (PUG), PUG, fist-in-man, first-in-human, ColombiaComment